ZA200809111B - Substituted carboxamides - Google Patents

Substituted carboxamides

Info

Publication number: ZA200809111B
Authority: ZA; South Africa
Prior art keywords: substituted carboxamides; substituted; carboxamides; formula; pharmaceutically acceptable
Prior art date: 2006-06-08

Application number

ZA200809111A

Other languages

English (en)

Inventor

Ryan Thomas Backer

Matthew Joseph Fisher

Steven Lee Kuklish

Sean Patrick Hollinshead

Edward C R Smith

Kumiko Takeuchi

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-08

Filing date

2008-10-23

Publication date

2009-12-30

2008-10-23 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2009-12-30 Publication of ZA200809111B publication Critical patent/ZA200809111B/xx

Links

150000003857 carboxamides Chemical class 0.000 title 1
-1 carboxamide compound Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA200809111A 2006-06-08 2008-10-23 Substituted carboxamides ZA200809111B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US81183906P	2006-06-08	2006-06-08

Publications (1)

Publication Number	Publication Date
ZA200809111B true ZA200809111B (en)	2009-12-30

Family

ID=39673278

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200809111A ZA200809111B (en)	2006-06-08	2008-10-23	Substituted carboxamides

Country Status (30)

Country	Link
US (1)	US7960419B2 (fr)
EP (1)	EP2076502B1 (fr)
JP (1)	JP5108878B2 (fr)
KR (1)	KR101051559B1 (fr)
CN (1)	CN101466691B (fr)
AT (1)	ATE509921T1 (fr)
AU (1)	AU2007347428B2 (fr)
BR (1)	BRPI0712862A2 (fr)
CA (1)	CA2652074C (fr)
CR (1)	CR10410A (fr)
CY (1)	CY1111588T1 (fr)
DK (1)	DK2076502T3 (fr)
EA (1)	EA014233B1 (fr)
EC (1)	ECSP088939A (fr)
ES (1)	ES2362949T3 (fr)
HR (1)	HRP20110436T1 (fr)
IL (1)	IL195632A (fr)
MA (1)	MA30620B1 (fr)
MX (1)	MX2008015485A (fr)
MY (1)	MY148084A (fr)
NO (1)	NO341474B1 (fr)
NZ (1)	NZ573352A (fr)
PL (1)	PL2076502T3 (fr)
PT (1)	PT2076502E (fr)
RS (1)	RS51818B (fr)
SI (1)	SI2076502T1 (fr)
TN (1)	TNSN08506A1 (fr)
UA (1)	UA95480C2 (fr)
WO (1)	WO2008103185A2 (fr)
ZA (1)	ZA200809111B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0804685D0 (en)	2008-03-13	2008-04-16	Univ Edinburgh	Therapeutic compounds and their use
BRPI0910692A2 (pt)	2008-04-04	2018-03-27	Lilly Co Eli	3-indazolil-4-piridilisotiazóis
EP2443113A1 (fr) *	2009-06-15	2012-04-25	The University Of Edinburgh	Composés amido-isothiazole et leur utilisation comme inhibiteurs de la 11 -hsd1 dans le traitement du syndrome métabolique et des troubles apparentés
KR101702159B1 (ko)	2009-09-16	2017-02-02	더 유니버시티 오브 에든버러	（４―페닐―피페리딘―1―일）―［５―（1ｈ―피라졸―４―일）―티오펜―３―일］―메탄온 화합물 및 그의 용도
ES2543692T3 (es)	2010-04-29	2015-08-21	The University Of Edinburgh	(8-aza-biciclo[3.2.1biciclo[oct-8-il)-[5-(1H-pirazol-4-il)-tiofeno-3-il]-metanonas 3,3-disustituidas como inhibidores de 11beta-HSD1
EP2921489B1 (fr)	2012-11-13	2017-09-06	Nissan Chemical Industries, Ltd.	Composé 2-pyridone
EP3515919A1 (fr)	2016-09-23	2019-07-31	Bayer Aktiengesellschaft	Thiéno-uraciles à substitution n3-cyclique et leur utilisation
CN117567266B (zh) *	2023-11-07	2024-06-14	康龙化成手性医药技术(宁波)有限公司	一种制备2-甲基环丙羧酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL72091A0 (en) *	1983-06-20	1984-10-31	Lilly Co Eli	N'-substituted(3-aryl 5-isothiazolyl)urea derivatives
DE4328425A1 (de) *	1993-08-24	1995-03-02	Basf Ag	Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung
DK124393D0 (da) *	1993-11-03	1993-11-03	Lundbeck & Co As H	Compounds
DE19542372A1 (de) *	1995-11-14	1997-05-15	Bayer Ag	Acylierte 5-Aminoisothiazole
UA60365C2 (uk) *	1998-06-04	2003-10-15	Пфайзер Продактс Інк.	Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
JP3411262B2 (ja) *	1999-08-20	2003-05-26	萬有製薬株式会社	新規スピロ化合物
BR0211742A (pt) *	2001-08-06	2004-08-24	Pharmacia Italia Spa	Derivados de aminoisoxazole ativos como inibidores de cinase
WO2005030128A2 (fr) *	2003-09-23	2005-04-07	Merck & Co., Inc.	Modulateurs pyrazole de recepteurs de glutamate metabotropiques
WO2005113534A2 (fr) *	2004-05-12	2005-12-01	Schering Corporation	Antagonistes de chimiokines cxcr1 et cxcr2
BRPI0515571A (pt) *	2004-09-23	2008-07-29	Pfizer Prod Inc	agonistas de receptor de trombopoetina

2007
- 2007-06-07 EP EP07873705A patent/EP2076502B1/fr active Active
- 2007-06-07 DK DK07873705.3T patent/DK2076502T3/da active
- 2007-06-07 EA EA200870516A patent/EA014233B1/ru not_active IP Right Cessation
- 2007-06-07 SI SI200730695T patent/SI2076502T1/sl unknown
- 2007-06-07 PL PL07873705T patent/PL2076502T3/pl unknown
- 2007-06-07 AT AT07873705T patent/ATE509921T1/de active
- 2007-06-07 CN CN2007800211890A patent/CN101466691B/zh not_active Expired - Fee Related
- 2007-06-07 MX MX2008015485A patent/MX2008015485A/es active IP Right Grant
- 2007-06-07 AU AU2007347428A patent/AU2007347428B2/en not_active Ceased
- 2007-06-07 WO PCT/US2007/070572 patent/WO2008103185A2/fr not_active Ceased
- 2007-06-07 BR BRPI0712862-2A patent/BRPI0712862A2/pt not_active IP Right Cessation
- 2007-06-07 JP JP2009514523A patent/JP5108878B2/ja not_active Expired - Fee Related
- 2007-06-07 CA CA2652074A patent/CA2652074C/fr not_active Expired - Fee Related
- 2007-06-07 KR KR1020087029772A patent/KR101051559B1/ko not_active Expired - Fee Related
- 2007-06-07 RS RS20110336A patent/RS51818B/sr unknown
- 2007-06-07 MY MYPI20084973A patent/MY148084A/en unknown
- 2007-06-07 UA UAA200813907A patent/UA95480C2/uk unknown
- 2007-06-07 US US12/300,415 patent/US7960419B2/en active Active
- 2007-06-07 NZ NZ573352A patent/NZ573352A/en not_active IP Right Cessation
- 2007-06-07 HR HR20110436T patent/HRP20110436T1/hr unknown
- 2007-06-07 ES ES07873705T patent/ES2362949T3/es active Active
- 2007-06-07 PT PT07873705T patent/PT2076502E/pt unknown
- 2007-10-29 CR CR10410A patent/CR10410A/es unknown
2008
- 2008-10-23 ZA ZA200809111A patent/ZA200809111B/xx unknown
- 2008-12-01 IL IL195632A patent/IL195632A/en not_active IP Right Cessation
- 2008-12-02 NO NO20085028A patent/NO341474B1/no not_active IP Right Cessation
- 2008-12-03 EC EC2008008939A patent/ECSP088939A/es unknown
- 2008-12-05 TN TNP2008000506A patent/TNSN08506A1/en unknown
2009
- 2009-01-06 MA MA31553A patent/MA30620B1/fr unknown
2011
- 2011-06-24 CY CY20111100600T patent/CY1111588T1/el unknown

Also Published As

Publication number	Publication date
UA95480C2 (uk)	2011-08-10
SI2076502T1 (sl)	2011-09-30
BRPI0712862A2 (pt)	2012-12-18
CY1111588T1 (el)	2015-10-07
TNSN08506A1 (en)	2010-04-14
PL2076502T3 (pl)	2011-09-30
EA014233B1 (ru)	2010-10-29
CA2652074A1 (fr)	2008-08-28
CN101466691B (zh)	2011-07-27
ES2362949T3 (es)	2011-07-15
DK2076502T3 (da)	2011-07-25
NO20085028L (no)	2008-12-02
MY148084A (en)	2013-02-28
PT2076502E (pt)	2011-06-07
WO2008103185A2 (fr)	2008-08-28
ECSP088939A (es)	2009-01-30
KR101051559B1 (ko)	2011-07-22
NZ573352A (en)	2011-10-28
CN101466691A (zh)	2009-06-24
RS51818B (sr)	2011-12-31
WO2008103185A3 (fr)	2008-10-30
NO341474B1 (no)	2017-11-27
CA2652074C (fr)	2013-08-06
JP2009539874A (ja)	2009-11-19
MA30620B1 (fr)	2009-08-03
MX2008015485A (es)	2009-03-06
IL195632A0 (en)	2009-09-01
EP2076502A2 (fr)	2009-07-08
HRP20110436T1 (hr)	2011-08-31
AU2007347428A1 (en)	2008-08-28
CR10410A (es)	2008-11-28
EP2076502B1 (fr)	2011-05-18
US20090182025A1 (en)	2009-07-16
KR20090008460A (ko)	2009-01-21
JP5108878B2 (ja)	2012-12-26
EA200870516A1 (ru)	2009-06-30
HK1131984A1 (en)	2010-02-12
ATE509921T1 (de)	2011-06-15
IL195632A (en)	2013-11-28
AU2007347428B2 (en)	2012-02-09
US7960419B2 (en)	2011-06-14

Publication	Publication Date	Title
IL195632A0 (en)	2009-09-01	Substituted carboxamides
MY146662A (en)	2012-09-14	Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
TW201000473A (en)	2010-01-01	Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
TW200806299A (en)	2008-02-01	Treatment of pain
TW200806300A (en)	2008-02-01	New therapeutic combinations for the treatment of depression
SI2205244T1 (sl)	2013-12-31	Postopki dajanja N-(5-terc.-butil-izoksazol-3-il)-N'-(4-(7-(2-morfolin- 4-il-etoksi-)imidazo-2,1-b)-(1,3)-benzotiazol-2-il)-fenil)sečnine za zdravljenje proliferativne bolezni
MX2010008460A (es)	2010-08-30	Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular.
UA93709C2 (ru)	2011-03-10	12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
ZA200806778B (en)	2009-11-25	N-Hydroxyacrylamide compounds
TW200738653A (en)	2007-10-16	Anthranilamide/2-amino-heteroarene carboxamide derivatives
MX2009005798A (es)	2009-08-12	Recuperacion de apoplejia.
TW200639159A (en)	2006-11-16	Treatment of pain
MX2009006325A (es)	2009-07-24	Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
TW200806321A (en)	2008-02-01	New therapeutic combinations for the treatment or prevention of psychotic disorders
TW200800993A (en)	2008-01-01	Organic compounds
MX2010008586A (es)	2010-08-23	Amidas de acido 3-(4-fluorofenil)-3-hidroxi-2-amino-propionico y compuestos relacionados que tienen actividad analgesica.
IL197769A (en)	2013-07-31	The history of morphine, medicinal preparations containing them and their use in the preparation of pain medication
WO2007144889A3 (fr)	2008-06-19	Traitement de neurofibromatose
WO2008130321A3 (fr)	2008-12-18	Nouveaux composés 807
MX2009010164A (es)	2009-10-12	Metodo para tratar dolor mediado por el receptor cb2.
MX2009010162A (es)	2009-10-12	Metodo para tratar dolor mediado por el receptor cb2.
EA200701086A1 (ru)	2007-12-28	Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли
UA103767C2 (ru)	2013-11-25	Карбоксамидные соединения для лечения метаболических расстройств